Cardiac Resynchronization Therapy Devices (CRT) arşivleri - Aventin Health https://aventinhealth.com/en/ Cardiac Rhythm Management, Heart Failure Thu, 13 Jan 2022 14:38:21 +0000 en-US hourly 1 https://wordpress.org/?v=5.9.1 https://aventinhealth.com/wp-content/uploads/2022/01/cropped-aventin-favicon-02-32x32.png Cardiac Resynchronization Therapy Devices (CRT) arşivleri - Aventin Health https://aventinhealth.com/en/ 32 32 Entrant HF Cardiac Resynchronization Therapy Defibrillator (CRT-D) https://aventinhealth.com/en/urunler/abbott-products/cardiovascular-products/cardiac-resynchronization-therapy-devices-crt/entrant-hf-cardiac-resynchronization-therapy-defibrillator-crt-d/ Thu, 13 Jan 2022 14:38:21 +0000 https://aventinhealth.com/urunler/uncategorized/entrant-hf-cardiac-resynchronization-therapy-defibrillator-crt-d/ Entrant™ HF CRT-D solutions use smartphone connectivity with extended therapy that you can intuitively program to make a powerful difference in the lives of your heart failure patients.

  • Get fast, effective CRT optimization with SyncAV CRT technology
  • Encourage greater patient engagement with app-based remote monitoring
  • Provide powerful, lasting therapy with a small, contoured design with 1.5T and 3T MR Conditional*

Entrant HF Cardiac Resynchronization Therapy Defibrillator (CRT-D) yazısı ilk önce Aventin Health üzerinde ortaya çıktı.

]]> Rx only

Intended Use: Cardiac Resynchronization Therapy Defibrillator (CRT-D) devices are intended to provide ventricular antitachycardia pacing and ventricular cardioversion/defibrillation. CRT-D devices are also intended to resynchronize the right and left ventricles.

Indications: CRT-D devices are indicated for the automated treatment of life-threatening ventricular arrhythmias. CRT-D devices are also indicated for treating symptoms in patients with congestive heart failure with ventricular dyssynchrony.

In addition, CRT-D devices with the AT/AF detection algorithm are indicated for patients with atrial tachyarrhythmias or patients at significant risk of developing atrial tachyarrhythmias.

MR Conditional CRT-Ds are conditionally safe for use in the MRI environment when used in a complete MR Conditional system and according to the instructions in the MRI-Ready Systems manual. Scanning under different conditions can result in serious patient injury, death, or device failure.

Contraindications: Contraindications to the use of the pulse generator system include ventricular tachyarrhythmias caused by transient or correctable factors such as drug toxicity, electrolyte imbalance, or acute myocardial infarction.

Entrant HF Cardiac Resynchronization Therapy Defibrillator (CRT-D) yazısı ilk önce Aventin Health üzerinde ortaya çıktı.

]]> Gallant HF Cardiac Resynchronization Therapy Defibrillator (CRT-D) https://aventinhealth.com/en/urunler/abbott-products/cardiovascular-products/cardiac-resynchronization-therapy-devices-crt/gallant-hf-cardiac-resynchronization-therapy-defibrillator-crt-d/ https://aventinhealth.com/en/urunler/abbott-products/cardiovascular-products/cardiac-resynchronization-therapy-devices-crt/gallant-hf-cardiac-resynchronization-therapy-defibrillator-crt-d/#respond Thu, 13 Jan 2022 14:08:38 +0000 https://aventinhealth.com/urunler/uncategorized/gallant-hf-cardiac-resynchronization-therapy-defibrillator-crt-d/ Gallant™ HF CRT-D solutions use smartphone connectivity with extended therapy that you can intuitively program to make a powerful difference in the lives of your heart failure patients.

  • Get fast, effective CRT optimization with SyncAV CRT technology
  • Encourage greater patient engagement with app-based remote monitoring
  • Provide powerful, lasting therapy with a small, contoured design with 1.5T and 3T MR Conditional*

Gallant HF Cardiac Resynchronization Therapy Defibrillator (CRT-D) yazısı ilk önce Aventin Health üzerinde ortaya çıktı.

]]> Rx only

Kullanım Amacı: Kardiyak Resenkronizasyon Tedavisi Defibrilatörü (CRT-D) cihazlarının ventriküler antitaşikardi pacing ve ventriküler kardiyoversiyon/defibrilasyon sağlaması amaçlanmıştır. CRT-D devices are also intended to resynchronize the right and left ventricles.

Indications: CRT-D devices are indicated for the automated treatment of life-threatening ventricular arrhythmias. CRT-D devices are also indicated for treating symptoms in patients with congestive heart failure with ventricular dyssynchrony.

In addition, CRT-D devices with the AT/AF detection algorithm are indicated for patients with atrial tachyarrhythmias or patients at significant risk of developing atrial tachyarrhythmias.

MR Conditional CRT-Ds are conditionally safe for use in the MRI environment when used in a complete MR Conditional system and according to the instructions in the MRI-Ready Systems manual. Scanning under different conditions can result in serious patient injury, death, or device failure.

Contraindications: Contraindications to the use of the pulse generator system include ventricular tachyarrhythmias caused by transient or correctable factors such as drug toxicity, electrolyte imbalance, or acute myocardial infarction.

Gallant HF Cardiac Resynchronization Therapy Defibrillator (CRT-D) yazısı ilk önce Aventin Health üzerinde ortaya çıktı.

]]> https://aventinhealth.com/en/urunler/abbott-products/cardiovascular-products/cardiac-resynchronization-therapy-devices-crt/gallant-hf-cardiac-resynchronization-therapy-defibrillator-crt-d/feed/ 0 Quadra Allure MP™ Cardiac Resynchronization Therapy Pacemaker (CRT-P) https://aventinhealth.com/en/urunler/abbott-products/cardiovascular-products/cardiac-resynchronization-therapy-devices-crt/quadra-allure-mp-cardiac-resynchronization-therapy-pacemaker-crt-p/ Thu, 13 Jan 2022 14:05:14 +0000 https://aventinhealth.com/urunler/uncategorized/quadra-allure-mp-cardiac-resynchronization-therapy-pacemaker-crt-p/ Quadra Allure MP™ CRT-P is a CRT-P with MultiPoint pacing technology. MultiPoint technology is designed to deliver multiple independent left ventricular (LV) pacing pulses from a single quadripolar lead. Quadra Allure MP CRT-P also offers automatic tissue region identification, comprehensive diagnostics and RF monitoring.

Quadra Allure MP™ Cardiac Resynchronization Therapy Pacemaker (CRT-P) yazısı ilk önce Aventin Health üzerinde ortaya çıktı.

]]> MultiPoint Pacing technology is designed to deliver multiple independent left ventricular (LV) pacing pulses from a single quadripolar lead to give you CRT options that you can change:

  • Depolarization pattern
  • Engagement of areas around scar tissue
  • Hemodynamics
  • Resync

Using the Quadra Allure MP CRT-P with the Quartet™ quadripolar LV pacing lead with four pacing electrodes and 14 pacing vectors provides more choice and more control over the CRT response.

US IDE STUDY: THE IMPORTANCE OF MPP™ TECHNOLOGY PROGRAMMING

The most recent IDE study1 post-hoc subanalysis (n = 199) showed that wider cathode spacing and nearly simultaneous intraventricular timing delays provided the best MPP technology response in 87 percent and a “super-response” in 54 percent (52 patients).

See details of the US IDE study and other clinical support for MultiPoint Pacing.

ADDITIONAL INTERNATIONAL CLINICAL DATA

This evidence is based on our quadrupole standard of care giving you more options for stepping up in the preferred LV region and has resulted in the following results:

  • Improved CRT result
  • Fewer surgical revisions
  • Reduced need for lead repositioning at the implant results in shorter procedure times and reduced fluoroscopic exposure
  • More baseline pacing opportunities without sacrificing lead stability
QUADRA ALLURE MP CRT-P ADVANCED FEATURES AND BENEFITS
Designed to Optimize Tissue Selection

Quadra Allure MP CRT-P offers the Auto VectSelect Quartet™ Test as:

  • Automatically identifies tissue regions with latest activation via RV-LV conduction delay measurements
  • Performs threshold testing, evaluates applicability of LVCap™ Validation and allows flagging of PNS

Pacing at the tissue site of the most recent activation improves:

  • acute hemodynamic response
  • Reverse remodeling
  • Life quality
Advanced Programming Options
  • SyncAV™ CRT technology automatically adjusts pacing based on real-time changes in the patient’s heart condition.
Providing Insightful Diagnostics and RF Monitoring

The Quadra Allure MP CRT-P helps you better manage your patients’ heart failure with intuitive programming options and provides timely access to vital heart failure diagnostic data via radio frequency (RF) monitoring and provides:

  • CorVue™ congestion monitoring for an earlier insight into HF progression
  • Daily remote monitoring of AT/AF alerts for changes in patient’s AF status
  • DirectTrend™ reports for a simplified view of all device data
COMPREHENSIVE HEART FAILURE MANAGEMENT

Quadra Allure MP™ CRT-P is one of our heart failure management treatments. Our vision is to transform heart failure treatment by designing technology that delivers excellent clinical results and improves workflow and efficiency.

Quadra Allure MP™ Cardiac Resynchronization Therapy Pacemaker (CRT-P) yazısı ilk önce Aventin Health üzerinde ortaya çıktı.

]]> Quadra Assura MP™ Cardiac Resynchronization Therapy Defibrillator (CRT-D) https://aventinhealth.com/en/urunler/abbott-products/cardiovascular-products/cardiac-resynchronization-therapy-devices-crt/quadra-assura-mp-cardiac-resynchronization-therapy-defibrillator-crt-d/ Thu, 13 Jan 2022 13:35:35 +0000 https://aventinhealth.com/urunler/uncategorized/quadra-assura-mp-cardiac-resynchronization-therapy-defibrillator-crt-d/ Quadra Assura MP™ CRT-D is a CRT-D that offers MultiPoint pacing technology. Quadra Assura MP CRT-D also offers advanced programming options along with multiple monitoring and security features.

Quadra Assura MP™ Cardiac Resynchronization Therapy Defibrillator (CRT-D) yazısı ilk önce Aventin Health üzerinde ortaya çıktı.

]]> MultiPoint Pacing technology is designed to provide multiple independent left ventricular (LV) pacing pulses from a single quadripolar lead to give you CRT options that you can change:

  • Depolarization pattern
  • Engagement of areas around scar tissue
  • hemodynamics
  • resync

Featuring a Quartet™ quadripolar LV pacing lead with four pacing electrodes and 10 pacing vectors, the Quadra Assura MP™ CRT-D provides more choice and more control over CRT response.

US IDE STUDY: THE IMPORTANCE OF MULTIPOINT™ PACING TECHNOLOGY PROGRAMMING

The most recent IDE study post-hoc subanalysis (n = 199) showed that wider cathode spacing and nearly simultaneous intraventricular timing delays provided the best MultiPoint Pacing technology response at 87 percent and a “super response” at 54 percent (52 patients). .

Learn more:

  • Read the full article on the US MultiPoint™ Pacing IDE study.
  • Visit our clinical evidence for MultiPoint Pacing.
Additional International Clinical Data

This evidence is based on our quadrupole standard of care giving you more options for stepping up in the preferred LV region and has resulted in the following results:

  • Improved CRT result
  • Fewer surgical revisions
  • Reduced need for lead repositioning at the implant results in shorter procedure times and reduced fluoroscopic exposure
  • More baseline pacing opportunities without sacrificing lead stability
QUADRA ASSURA MP CRT-D ADVANCED FEATURES AND BENEFITS
MRI Ready Now

The Quadra Assura MP CRT-D is MR conditional when used with specific leads and lead lengths and allows full body, 1.5T MRI scans that meet specific scan conditions.*

  • Meets industry standard MRI testing requirements
  • Can do full body 1.5T MRI imaging scans
Designed to Optimize Texture Selection

Quadra Assura MP RF CRT-D offers the Auto VectSelect Quartet™ Test as:

  • Automatically identifies tissue regions with latest activation via RV-LV conduction delay measurements
  • Performs threshold testing, evaluates LVCap™, confirms applicability, and flags PNS

Pacing at the tissue site of the most recent activation improves:

  • acute hemodynamic response
  • Reverse remodeling
  • Life quality
Advanced Programming Options
  • SyncAV™ CRT technology automatically adjusts pacing based on real-time changes in the patient’s heart condition.
  • Antitachycardia pacing (ATP) during charging and before charging in the VF region further expands programming options to terminate tachyarrhythmias without high voltage shock.
  • The SenseAbility™ feature provides flexibility to fine-tune programming around T-wave oversensing without reducing sensitivity.
Additional Monitoring and Security Features
  • ShockGuard™ technology with DecisionTx™ programming
  • SecureSense™ RV lead noise discrimination
  • Far Field MD™ morphology discrimination
  • DeFT Response™ technology
  • CorVue™ congestion monitoring
  • QuickOpt™ timing loop optimization

Quadra Assura MP™ Cardiac Resynchronization Therapy Defibrillator (CRT-D) yazısı ilk önce Aventin Health üzerinde ortaya çıktı.

]]>